FDA
approval
· 2023-03-31
FDA Approved: PREZISTA — Supplemental Application (Janssen Products LP)
Summary
FDA approved a supplemental application for PREZISTA (darunavir) submitted by Janssen Products LP.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for PREZISTA (DARUNAVIR)